Mizuho has raised its price target on Intel (NASDAQ: INTC) from $20 to $23, maintaining a Neutral rating, citing potential ...

Investing.com-- Mizuho hiked its price target on Intel (NASDAQ: INTC ), stating that the beleaguered chipmaker’s foundry unit ...

A string of thefts involving bank employees have intensified scrutiny on a segment already grappling with weak demand and ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Mizuho Securities analyst Vijay Rakesh maintained a Hold rating on Intel (INTC – Research Report) today and set a price target of $23.00. The ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Ratings ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharmaceutical company that develops and commercializes therapies ...

Churchill Downs (NASDAQ:CHDN – Free Report) had its target price cut by Stifel Nicolaus from $164.00 to $161.00 in a report ...

Yoshiko Abe is about to turn 89, but that hasn't stopped her from going to the gym every day and trying the free-of-charge ...